Blocking PD-L1 on tumor is generally considered to enhance the activity of effector T cells (Fig. 4C) in the tumour micro-environment, and it also enhanced NK cell (Fig. 4D) activity and may enhance production through indirectly or direct effects on PD-1+ B cells21. This evidence concerns the gene CD274 and neoplasm.